intratio Posted - 4 days ago

https://www.intratio.com/stock-forecast/NRIX The statistical model has detected that the value of this equity will lose ground in the coming days with a clear pessimistic long-term perspective $NRIX

intratio Posted - 1 week ago

$NRIX https://www.intratio.com/stock-forecast/NRIX Our trained A.I. reaches the conclusion the price action of this stock will shortly go down and is facing massive downsides in the longer term

oaksapollo Posted - 1 week ago

$NRIX Look at July call bids. Crazy high bids for $25, $30 calls. Very unusual. They're not trading so maybe someone just messing around. Once April calls expire, I'll see if I can actually sell a substantial number of $30 contracts at $0.40-0.70. Seems like a sweet deal.

Stock_Titan Posted - 2 weeks ago

$NRIX Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares https://www.stocktitan.net/news/NRIX/nurix-therapeutics-announces-closing-of-public-offering-and-full-nop9tu6ocduk.html

pepe7 Posted - 2 weeks ago

$NRIX

OpenOutcrier Posted - 2 weeks ago

$NRIX (-5.6% pre) Nurix Therapeutics (NRIX) Prices Upsized 10.17M Share Offering at $15/sh - SI https://ooc.bz/l/30225

BPharmCatalyst Posted - 2 weeks ago

$PXMD completed the execution of its three pivotal registration/validation batches of PAX-101, an IV formulation of suramin. This achievement is an important milestone to enabling a New Drug Application (NDA) submission to the FDA, which is currently planned for Q4 2024, and for the potential commercial availability in the U.S. of the first and only form of suramin for the treatment of Stage 1 Human African Trypanosomiasis (HAT). See More Pre-market Movers 👇 https://www.biopharmcatalyst.com/news/2024/paxmedica-pxmd-batch-update-allarity-allr-offering $ALLR $SNGX $OCX $NRIX $MOTX

briefingcom Posted - 2 weeks ago

Gapping down: $APLD -10.1% $NRIX -6% $ONEW -2% $JPM -2%

DonCorleone77 Posted - 2 weeks ago

$NRIX Nurix Therapeutics 10.2M share Spot Secondary priced at $15.50 The deal size was raised to $175M in common stock and prefunded warrants from $125M and priced within the $14.50-$15.50 range. JPMorgan, Piper Sandler and Stifel acted as joint book running managers for the offering.

Stock_Titan Posted - 2 weeks ago

$NRIX Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering https://www.stocktitan.net/news/NRIX/nurix-therapeutics-announces-pricing-of-upsized-175-0-million-public-nhew29z5sb10.html

1logicaltrader Posted - 2 weeks ago

I am short $NRIX solely on the news, BUT, next time someone tells you "They won't do an offering they have cash" You can remind them of this one. This company shows they have cash, yet still 125m offering. This usually means the hard will not be that dramatic and some positive press is coming again. I said usually, not always! This was a scalp from 16.85, not retiring from it and will cover whenever I want.

DonCorleone77 Posted - 2 weeks ago

$NRIX Nurix Therapeutics $125M Spot Secondary; price range $14.50-$15.50 JPMorgan, Piper Sandler and Stifel are acting as joint book running managers for the offering.

DonCorleone77 Posted - 2 weeks ago

$NRIX Nurix Therapeutics announces $125M common stock offering Nurix Therapeutics announced that it has commenced an underwritten public offering of $125M of its common stock and, in lieu of common stock, in the case of certain investors, pre-funded warrants to purchase shares of its common stock. All of the securities will be offered and sold by Nurix. Nurix currently intends to use any net proceeds from this offering primarily to fund clinical development of its drug candidates, to fund research and development activities to expand its pipeline and for working capital and general corporate purposes. J.P. Morgan Securities, Piper Sandler & Co. and Stifel, Nicolaus & Company are acting as joint book-running managers for the proposed offering. Needham & Company and RBC Capital Markets are acting as lead managers for the proposed offering.

Stock_Titan Posted - 2 weeks ago

$NRIX Nurix Therapeutics Announces Proposed Public Offering https://www.stocktitan.net/news/NRIX/nurix-therapeutics-announces-proposed-public-pekvhud33dwn.html

oaksapollo Posted - 2 weeks ago

$NRIX I just sold May $30 covered calls for $0.29. That tells you all you need to know.

Fullratio Posted - 2 weeks ago

$NRIX debt has surged by 173% year-on-year but it is down by 4.8% since the previous quarter: https://fullratio.com/stocks/nasdaq-nrix/nurix-therapeutics

StockDeals Posted - 2 weeks ago

$NRIX towards 19.5 🤔?

Fullratio Posted - 2 weeks ago

$NRIX total assets is 129% greater than its total liabilities: https://fullratio.com/stocks/nasdaq-nrix/nurix-therapeutics

Quantumup Posted - 2 weeks ago

JPM $NRIX OW/$30 W/ generally growing appreciation of the clinical pot of the BTK degrader class/ $NRIX 's pipeline positioning w/in it, JPM anticipates the mid-Y NX-5948 Ph1 update in CLL + contd progress 2ward pipeline exp in I&I =levers4shrs2remain constructive: #AARC $SNY $GILD

briefingcom Posted - 2 weeks ago

$NRIX: Nurix Therapeutics beats by $0.02, slightly misses on revs https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240410070513NRIX&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

GSP Posted - 2 weeks ago

$LULU $WAVE $SPY $NIU $NRIX

briefingcom Posted - 2 weeks ago

Gapping down: $SOUN -8.8% $HXL -8.7% $DCGO -6.7% $NRIX -3% $WDFC -2.6%

epsguid Posted - 2 weeks ago

$NRIX reported a loss of $0.76, consensus was ($0.80) via @eWhispers #epsbeat http://eps.sh/d/nrix

DonCorleone77 Posted - 2 weeks ago

$NRIX Nurix Therapeutics reports Q1 EPS (76c), consensus (80c) Reports Q1 revenue $16.6M, consensus $16.64M. Nurix had a strong start to 2024 with the recent announcements of the extensions of our collaborations with both Gilead and Sanofi further validating the power of our platform and the expansion of our work in inflammatory diseases with Sanofi, including the STAT6 program, one of the most exciting targets in inflammation," said Arthur T. Sands, M.D., Ph.D., president and chief executive officer of Nurix. "We look forward to the continued advancement of our exciting clinical pipeline led by NX-5948 in addition to our other wholly owned and partnered programs."

Stock_Titan Posted - 2 weeks ago

$NRIX Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update https://www.stocktitan.net/news/NRIX/nurix-therapeutics-reports-first-quarter-fiscal-2024-financial-yw9l7yu75ih7.html

Thestocktraderhubzee Posted - 2 weeks ago

WATCHLIST APR 10 2024 $HOLX Needham Reiterates Buy on Hologic, Maintains $90 Price Target $NRIX Needham Reiterates Buy on Nurix Therapeutics, Maintains $31 Price Target $GDRX Keybanc Upgrades GoodRx Holdings to Overweight, Announces $9 Price Target $AUGX Evercore ISI Group Upgrades Augmedix to Outperform, Raises Price Target to $5 $TGLS B. Riley Securities Maintains Buy on Tecnoglass, Raises Price Target to $65

GSP Posted - 3 weeks ago

$NRIX made a nice move today. It probably needs to rest a bit, but I'll have it on a chart in front of me tomorrow.

jaydilks Posted - 3 weeks ago

$ARKG Today’s leaders. $NRIX $ABSI $MRNA

GSP Posted - 3 weeks ago

Day Trading Watch List Video for April 10th: $SPY $LULU $WAVE $NIU $NRIX Watch here: https://greatstockpix.com/april-10th-day-trading-watch-list/

momeymaker1 Posted - 3 weeks ago

$NRIX 💪